DJIA 16,327.04 -53.37 -0.33%
NASDAQ 4,274.84 16.40 0.39%
S&P 500 1,888.15 1.39 0.07%
market minute promo


3.46 0.10 (2.98%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $3.43 2.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.37
Previous Close $3.36
Daily Range $3.34 - $3.44
52-Week Range $3.13 - $10.29
Market Cap $358.0M
P/E Ratio -3.23
Dividend (Yield) $0.00 (0.0%)
Volume 71,438
Average Daily Volume 3,141,488
Current FY EPS -$1.06





VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary

3 Biotech Stocks Near 52-Week Lows Worth Buying

These may be cheap biotech stocks, but they may not be cheap for long according to the three analysts we asked.

What To Watch For As Orexigen's Launch Approaches

Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog

Orexigen On A Tear - In The Wrong Direction

Is VIVUS Inc. a Short Sell?

Shares of VIVUS Inc. have crashed by over 60% in the past year. Is the stock still a good short sell?

Premature Combination Use Of Belviq And Phentermine Is A Risk

Belviq Sales Benefit From Advertising - Up 2.8%

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog

See More VVUS News...

VVUS's Top Competitors

VVUS $3.46 (2.98%)
Current stock: VVUS
JNJ $98.98 (0.28%)
Current stock: JNJ
NVS $87.02 (0.45%)
Current stock: NVS
RHHBY $35.37 (-0.11%)
Current stock: RHHBY